Strip companies tried to kill Livongo. Sanofi DTx distro.

Issue 041. Get E&O weekly. | Subscribe

Digital health research from Brian Dolan.

Welcome to E&O.

Last week's newsletter had a 63 percent open rate. Here's what's happening this week:

After a hiatus from public speaking, I got back on-stage last night at the MIT Sloan Healthcare Innovations Prize startup pitch competition. Have to admit I felt a bit rusty, but it was fun to hand out over-sized checks to the winners: The top three split $25,000.
Eddie Martucci and Corey McCann, the CEOs of Akili Interactive and Pear Therapeutics, respectively, met with the FDA's CDRH head Jeff Shuren earlier this month, according to Shuren's public calendar. The meeting focused on "Digital Therapeutic Devices" but the agency didn't disclose any additional information or attendees. Uncommon for two CEOs to meet with the FDA together without representing some other association or group. DTx is still early

Paying Subscribers Only

It's a good one, too.

This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!

Strip companies tried to kill Livongo. Sanofi DTx distro.

Welcome to E&O.

Paying Subscribers Only

Full access to E&O's research and newsletters.

New! E&O's free weekly newsletter.